H. Ralph Snodgrass
Overview
H. Ralph Snodgrass received an average of $842K in total compensation, including $355K in salary, at Vistagen Therapeutics from 2015 to 2020.
Source: SEC filings on July 27, 2020 and August 5, 2016.
Related executives
We found seven more executives who work or worked at Vistagen Therapeutics.
Shawn Singh
Vistagen Therapeutics
Chief Executive Officer
Reid Adler
Vistagen Therapeutics
General Counsel
Joshua Prince
Vistagen Therapeutics
Chief Operating Officer
Cynthia Anderson
Vistagen Therapeutics
Chief Financial Officer
Jerrold Dotson
Vistagen Therapeutics
Chief Financial Officer
Mark Smith
Vistagen Therapeutics
Chief Medical Officer
Mark McPartland
Vistagen Therapeutics